Clinitech Laboratory Stock Screener | Share Price & Fundamental Analysis

CTLLAB Healthcare Service Provider
Track Clinitech Laboratory share price live with TickJournal's free stock screener. Browse CTLLAB financial statements to support your investment research. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Clinitech Laboratory Market Cap ₹8.20 Cr.
CTLLAB P/E Ratio (TTM) -
Clinitech Laboratory P/B Ratio 0.93
EPS (TTM) ₹1.90
Dividend Yield -
Debt to Equity 0.07
CTLLAB 52 Week High -
Clinitech Laboratory 52 Week Low -
Operating Margin -
Profit Margin -
CTLLAB Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹11.00
Total Equity ₹9.00

Clinitech Laboratory Share Price History - Stock Screener Chart

Screen CTLLAB historical share price movements with interactive charts. Analyze price trends and patterns.

Clinitech Laboratory Company Profile - Fundamental Screener

Screen Clinitech Laboratory company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CTLLAB shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE0QMR01015

Clinitech Laboratory Balance Sheet Screener

Screen CTLLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021
Assets
Total Assets 11 6 6 4 3
Current Assets 7 3 2 1 2
Fixed Assets 2 2 1 2 1
Liabilities
Total Liabilities 0 0 0 0 0
Current Liabilities 0 0 2 1 1
Non-Current Liabilities 0 0 0 0 0
Shareholders' Equity
Total Equity 9 4 2 2 1
Share Capital 2 2 2 2 1
Reserves & Surplus 7 2 1 0 1

Clinitech Laboratory Income Statement Screener - Profit & Revenue Analysis

Screen Clinitech Laboratory income statement and profit fundamentals. Analyze CTLLAB quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Clinitech Laboratory share price evaluation.
Item None-None 2025-March 2024-March 2023-March 2022-March 2021-March
Revenue 0 9 6 6 7 5
Expenses 0 7 5 5 5 4
EBITDA 0 1 1 1 1 1
Operating Profit % 0.00% 10.00% 16.00% 21.00% 17.00% 18.00%
Depreciation 0 0 0 0 0 0
Interest 0 0 0 0 0 0
Profit Before Tax 0 1 1 1 1 1
Tax 0 0 0 0 0 0
Net Profit 0 0 0 1 1 0
EPS 0.00 1.90 2.37 4.09 3.42 6.04

Clinitech Laboratory Cash Flow Screener - Liquidity Fundamentals

Screen CTLLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March
Operating Activities -1 -1 1 1 0
Investing Activities -1 1 -1 -2 1
Financing Activities 4 0 0 0 -1
Net Cash Flow 2 0 1 0 0

Clinitech Laboratory Shareholding Pattern Screener

See Clinitech Laboratory shareholding pattern with promoter, FII, and DII holdings. Check Clinitech Laboratory promoter holding and ownership changes for CTLLAB on TickJournal.
Item 2025-Mar 2025-Sept 2024-Jan 2024-Jul 2024-Sept
Promoter Holding 61.58% 62.42% 83.63% 61.58% 61.58%
FII Holding 0.32% 0.32% 0.00% 0.32% 0.32%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 36.28% 35.91% 0.00% 33.81% 35.91%
Other Holding 1.83% 1.36% 16.37% 4.30% 2.20%
Shareholder Count 303 303 24 450 346

Clinitech Laboratory Share Dividend Screener - Share Yield Analysis

Check Clinitech Laboratory dividend history with payout and yield data. View Clinitech Laboratory dividend details including ex-dates and amounts for CTLLAB stock.
No dividends declared by Clinitech Laboratory.

Clinitech Laboratory Stock Index Membership

See which indices include Clinitech Laboratory stock. Check CTLLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Clinitech Laboratory is not part of any tracked indices.
Only major market indices are tracked in our system.

Clinitech Laboratory Market Events Screener - Corporate Actions

Get Clinitech Laboratory corporate actions including splits, bonuses, and buybacks. Check Clinitech Laboratory stock events that may affect CTLLAB share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -14.50%
2025-11-12 2025-11-12 Quarterly Result Announcement NA 4.76%
2025-05-23 2025-05-23 Quarterly Result Announcement NA 0.00%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -1.22%

Clinitech Laboratory Competitors Screener - Peer Comparison

Screen CTLLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 23,119 44.08 2,555 11.28% 492 53.95
Vijaya Diagnostic Centre 10,190 63.10 700 23.06% 144 63.89
Metropolis Healthcare 9,586 57.32 1,346 10.64% 146 55.51
Thyrocare Technologies 6,332 46.76 702 20.80% 91 59.36
Nephrocare Health Services 5,795 78.04 770 33.97% 67 60.45
Krsnaa Diagnostics 1,929 24.10 743 16.70% 78 50.09
Suraksha Diagnostic 1,437 44.50 256 15.11% 31 61.25
One Global Service Provider 1,142 18.72 148 134.60% 19 50.98
3B BlackBio DX 1,021 18.04 112 28.72% 48 42.56
Sastasundar Ventures 856 29.47 1,171 -18.47% -134 43.72

Clinitech Laboratory Company Announcements - News Screener

Screen CTLLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-04-09 General Update Under Reg 30 Of SEBI (LODR) Regulations For Change In Market Maker -
2026-04-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-06 General Update W.R.T Receipt Of Letter From Promoter Under Reg 31(4) Of SEBI (SAST) Regulations For The Year Ended March 31 2026 -
2026-03-30 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-30 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-28 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-27 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-24 Closure of Trading Window -
2026-03-20 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-18 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-14 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-12 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-03-10 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-02-17 Announcement Under Reg 30 Of SEBI (LODR)- Update W.R.T Incorporation Of Subsidiary -
2026-02-06 Board Meeting Outcome for Outcome Of 09Th Board Meeting Held Today At Its Registered Office -
2026-01-27 Board Meeting Outcome for Outcome Of 08Th Board Meeting For FY 2025-26 Thorugh Video Conferencing -
2026-01-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-19 General Update W.R.T Incorporation Of Subsidiary Of The Company -
2025-11-22 Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Sturday November 22 2025 At 11.30 A.M -
2025-11-19 Board Meeting Intimation for Board Meeting To Be Held On Saturday November 22 2025 At Its Registered Office At 11.30 A.M -